Loading…
for educational and safety purposes
RAD-140 and Ostarine both come up in the same conversations; they overlap on Muscle Growth. RAD-140: RAD-140, also known as testolone, is an experimental selective androgen receptor modulator, or SARM, a class of nonsteroidal compounds designed to stimulate muscle and bone growth while causing fewer of the unwanted effects of anabolic steroids. Ostarine: Ostarine, known in drug development as enobosarm or MK-2866, is an investigational selective androgen receptor modulator (SARM).
RAD-140, also known as testolone, is an experimental selective androgen receptor modulator, or SARM, a class of nonsteroidal compounds designed to stimulate muscle and bone growth while causing fewer of the unwanted effects of anabolic steroids. It was created by a pharmaceutical company as a potential treatment for conditions such as muscle wasting and, later, hormone-sensitive breast cancer, but it has not been approved for any medical use. Despite this, it is sold online and misused for bodybuilding, a practice associated with reports of liver and heart injury, and it is banned in sport by anti-doping authorities.
Ostarine, known in drug development as enobosarm or MK-2866, is an investigational selective androgen receptor modulator (SARM). SARMs are compounds designed to stimulate the androgen receptor in a tissue-selective way, aiming to build muscle and bone like anabolic steroids but with fewer effects on organs such as the prostate. Ostarine has been studied mainly for the muscle wasting associated with cancer and related conditions, but it is not approved as a medicine anywhere; it is prohibited in sport and has been the subject of regulatory warnings over its sale in bodybuilding and supplement products.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
selective agonist (SARM)
Agonist (tissue-selective)
stresses (risk)
weak agonist
Suppresses
Lowers
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.